Reduction in brain insulin signaling and/or insulin resistance is a prominent feature of type 2 diabetes mellitus, obesity, Alzheimer’s disease, and Parkinson’s disease1–4. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.